Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

In a significant advancement for prostate cancer research, a first-of-its kind study led by Emory researchers uncovered how the disease transforms ...

Faith in the possibility of 'enhancing' humankind – the extension human abilities and lifespan by any technological means – ...

DelveInsight's Diabetes pipeline report depicts a robust space with 200+ active players working to develop 200+ pipeline ...

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...

Up to 40% of ER-positive breast cancers have a PIK3CA mutation and are associated with poor prognosis; this approval helps address an urgent unmet need2-4 Itovebi is the first PI3K-targeted therapy to ...

The aim of the present study was to investigate the possible role of one such molecule, namely, insulin-like growth factor I, in myocardial hypertrophy developed in response to renal artery stenosis.

Current treatments for DED aim at lubricating and controlling inflammation of the ocular surface. Development of novel therapies targeting different pathogenic mechanisms is sought-after. The aim of ...

Preparation, gene mapping and PRimed IN Situ (PRINS) labeling on pachytene bivalents have already been conducted successfully in human, hamster and rice-field eels 2, 3, 4, 5.